Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica N Lamkin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Trends in Pharmacological Sciences|May 21, 2026
Remibrutinib (Rhapsido) for chronic spontaneous urticariaErica N Lamkin, Eduardo Bravo, Justin Taylor
Genes|September 27, 2025
Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted TherapySamantha Sekeres, Erica N Lamkin, Eduardo Bravo, et al.
Gland Surgery|February 11, 2026
The rural-urban paradox: rethinking delays in breast cancer careJavier I J Orozco, Erica N Lamkin, Olivia K Mihulka, et al.
Trends in Pharmacological Sciences|June 19, 2026
July 2026 issue first authorsRen-Lei Ji, Shubham Garg, Erica N Lamkin, et al.
Biochemical and Biophysical Research Communications|October 2, 2021
SARS-CoV-2 triggers DNA damage response in Vero E6 cellsJoshua Victor, Jamie Deutsch, Annalis Whitaker, et al.
Genes|January 28, 2026
REV1 Loss Triggers a G2/M Cell-Cycle Arrest Through Dysregulation of Mitotic RegulatorsBrailey Buntin, Madison Guyette, Vihit Gupta, et al.
Cancers|November 13, 2021
REV1 Inhibition Enhances Radioresistance and AutophagyKanayo E Ikeh, Erica N Lamkin, Andrew Crompton, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Trends in Pharmacological Sciences|May 21, 2026
Remibrutinib (Rhapsido) for chronic spontaneous urticariaErica N Lamkin, Eduardo Bravo, Justin Taylor
Genes|September 27, 2025
Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted TherapySamantha Sekeres, Erica N Lamkin, Eduardo Bravo, et al.
Gland Surgery|February 11, 2026
The rural-urban paradox: rethinking delays in breast cancer careJavier I J Orozco, Erica N Lamkin, Olivia K Mihulka, et al.
Trends in Pharmacological Sciences|June 19, 2026
July 2026 issue first authorsRen-Lei Ji, Shubham Garg, Erica N Lamkin, et al.
Biochemical and Biophysical Research Communications|October 2, 2021
SARS-CoV-2 triggers DNA damage response in Vero E6 cellsJoshua Victor, Jamie Deutsch, Annalis Whitaker, et al.
Genes|January 28, 2026
REV1 Loss Triggers a G2/M Cell-Cycle Arrest Through Dysregulation of Mitotic RegulatorsBrailey Buntin, Madison Guyette, Vihit Gupta, et al.
Cancers|November 13, 2021
REV1 Inhibition Enhances Radioresistance and AutophagyKanayo E Ikeh, Erica N Lamkin, Andrew Crompton, et al.
Pageof 1